Clinical Trials Logo

Filter by:
NCT ID: NCT05298761 Not yet recruiting - Clinical trials for Hemodynamic Stability

Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery

Start date: December 30, 2023
Phase: Early Phase 1
Study type: Interventional

Comparison of I/V nalbuphine versus I/V xylocain in attanuation of pressor response during intubation and laryngeoscopy in patients undergoing for thyroid surgery,selection of better supressor agent minimises the drug repated side effects like hypertention tachycardia but also helps in heamodynamically stability at induction.

NCT ID: NCT05255848 Not yet recruiting - COVID-19 Pneumonia Clinical Trials

Nebulised Heparin in Patients With COVID-19 Pneumonia

Start date: June 20, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

While the pandemic continues to incite panic and the guideline recommendations regarding management of COVID continue to change, we have growing evidence that ARDS secondary to Covid-19 is associated with disseminated intravascular and alveolar fibrin deposition1. Strategies devised to reduce mucous and fibrin plugs will greatly help in preventing patients from progressing to invasive ventilation2 which if happens will obviously overburden the compromised intensive care facilities. Offering heparin in nebulized form has greatly reduced levels of coagulation activation in the lungs both in animal studies and in patients with acute lung injury3. As Heparin prevents further fibrin deposition but is ineffective in the removal of pre-existing fibrin plug, so early use of heparin during the course of the disease may help in limiting the complications of ARDS and hence reducing the burden faced by our intensive care units. A prospective randomized controlled trial will be carried out in patients admitted to COVID complex to see its effects on disease progression and its role in preventing patients from progressing to require Invasive Mechanical Ventilation while being administered through local route rather than systemic. Moreover, it will also give insight and way forward regarding the improvement in the survival and earlier discharge

NCT ID: NCT05206851 Not yet recruiting - Low Back Pain Clinical Trials

Effects of Manual Lymphatic Drainage on Pregnancy Induced Lumbo-Pelvic Pain

Start date: April 2022
Phase: N/A
Study type: Interventional

This study will be a randomized controlled trial. This study will be conducted in Civil Hospital, Hassan Abdal. A sample size of 32 patients will be taken. Patients will be divided into two groups by lottery method. Group A will be treated with hot pack followed by Manual Lymphatic Drainage while Group B will be given home based plan of hot pack application only. Both groups will receive treatment for 4 weeks,2 sessions per week. The outcome measures Numeric pain rating scale(NPRS), QOL-GRAV and Oswestry Disability Index for back. Data will be analyzed by SPSS 21.

NCT ID: NCT05174741 Not yet recruiting - Asthma Clinical Trials

Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.

Start date: April 2023
Phase: N/A
Study type: Interventional

To determine the effect of pulmonary rehabilitation on pulmonary function in non-chronic obstructive pulmonary disease patients.To determine the effect of pulmonary rehabilitation on health related quality of life in non-chronic obstructive pulmonary disease patients.Limited researches are available in non chronic obstructive pulmonary disease patients.

NCT ID: NCT05162482 Not yet recruiting - COVID 19 Vaccine Clinical Trials

Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)

COMBAT-COVID
Start date: March 1, 2022
Phase: Phase 2
Study type: Interventional

This is a randomized, phase II trial which will be conducted among volunteers aged 18 years and above in Karachi, Lahore and Islamabad, Pakistan. The trial will have nine arms and is an open label study. Trained persons will administer the vaccine and draw blood under strict aseptic measures. The immune responses using pseudo neutralizing antibodies against SARS-CoV-2 in COVID-19 seronegative participants receiving heterologous and homologous COVID-19 vaccines will be assessed. Anti-spike IgG antibodies by ELISA and pseudo neutralizing antibodies against SARS-CoV-2 will also be measured. The safety and reactogenicity will also be assessed by recording serious adverse events (SAE), adverse events of special interest (AESI), solicited local and systemic reactions and medically attended adverse reactions through biochemical and hematological tests or safety measures throughout the study. In most cases the adverse events are mild and self-limiting but can require medication and/or hospitalization in rare cases. Participants suffering from any adverse event causally related to the to the trial intervention will be facilitated and the cost of treatment including laboratory investigations will be provided to them. Data confidentiality will be ensured by delinking names in forms and through password protection.

NCT ID: NCT05106790 Not yet recruiting - Clinical trials for Treatment Adherence and Compliance

A Factorial Approach to Improve Treatment Adherence and Systolic Blood Pressure

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

In Pakistan, poor medication adherence is a key operational factor in the prevalence of uncontrolled hypertension. Mobile phone treatments based on technology are at the forefront and are a reasonably low-cost strategy for combating the latest health concerns associated with poor adherence. On the other hand, conservative approaches to counseling are also found effective. This study will look at how a mHealth-based strategy and an educational-led peer counseling intervention can help hypertensive patients with coronary artery disease lower their systolic blood pressure.

NCT ID: NCT05089981 Not yet recruiting - Clinical trials for Acute on Chronic Liver Failure(ACLF)

Intravenous NAC Use in ACLF Patients

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Primary Objective To evaluate the efficacy and safety of 72 hour NAC treatment regimen in the management of ACLF Secondary Objective To evaluate the six weeks mortality and length of hospital stay in ACLF patients treated with NAC Randomized, Double blind pilot study of IV N-Acetyl cysteine for the treatment of ACLF. Participants will be randomized into intervention and control arm using block randomization by computer generated random numbers. Efficacy will be assessed by clinical improvement in symptoms and signs of decompensated chronic liver disease (CLD). To assess safety degree of adverse reactions will be observed. Periodic assessments until 28 day will be done consisting of Physical exam, safety assessments, vital signs and lab tests. Dose of Drug: 72 hour regimen consisting of three doses of intravenous N-Acetyl cysteine will be used for a total dose of 300mg/kg. Number of Patients: 100 Accrual period: 15 months

NCT ID: NCT05088928 Not yet recruiting - COVID-19 Clinical Trials

Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care

ECRU
Start date: March 1, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the study is to describe the safety and efficacy outcomes of a cohort of ICU patients with severe COVID-19 respiratory disease treated with therapeutic dose Apixaban for COVID-19 at a tertiary public health care setting.

NCT ID: NCT05053490 Not yet recruiting - Physical Fitness Clinical Trials

Static Versus Dynamic Stretching; Short Term Effects On Physical Performance In Non-Athletes

Start date: December 24, 2021
Phase: N/A
Study type: Interventional

This study will compare the short-term effects of static and dynamic stretching on the physical performance of undergraduate students who are not involved in athletic activities. It will be observed if a significant difference lies between these stretchings.

NCT ID: NCT05038774 Not yet recruiting - Hypertension Clinical Trials

Educational Intervention for Hypertension Management

Start date: September 30, 2021
Phase: N/A
Study type: Interventional

An interventional study is designed and a structured educational session will be conducted regarding the management of Blood pressure for the general physicians of Karachi, Lahore, Peshawar, Islamabad, Multan and Quetta. The purpose of designing this study is to observe the effect of hypertension educational intervention for general physicians to improve patient outcomes indirectly. Results of this study may provide a basis for developing a hypertension educational program targeted at general physicians.